Company Filing History:
1 out of 2,108 
1 out of 69 
Years Active: 2018
Title: Brian Buttrick: Innovator in Cytochrome P450 Research
Introduction
Brian Buttrick is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemistry, particularly in the area of cytochrome P450 research. His work focuses on developing specific inhibitors that can impact retinoic acid metabolism, which is crucial for treating various diseases.
Latest Patents
Brian Buttrick holds a patent for "Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase." This patent outlines compositions and methods for treating diseases that benefit from the inhibition of CYP26 mediated retinoic acid metabolism. The compositions include compounds that are designed to interact with specific molecular structures, providing a targeted approach to treatment.
Career Highlights
Throughout his career, Brian has worked at prestigious institutions such as the University of Washington and the University of Montana. His research has contributed to a deeper understanding of biochemical processes and has potential implications for therapeutic applications.
Collaborations
Brian has collaborated with esteemed colleagues, including Philippe Diaz and Nina Isoherranen. These partnerships have enhanced his research and expanded the impact of his work in the scientific community.
Conclusion
Brian Buttrick's innovative research in cytochrome P450 inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new treatment options and highlight the importance of collaboration in research.